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Abstract 
Recessive mutations in the MPV17 gene cause mitochondrial DNA depletion syndrome, a fatal infantile genetic liver 
disease in humans. Loss of function in mice leads to glomerulosclerosis and sensineural deafness accompanied with 
mitochondrial DNA depletion. Mutations in the yeast homolog Sym1, and in the zebra fish homolog tra cause inter‑
esting, but not obviously related phenotypes, although the human gene can complement the yeast Sym1 mutation. 
The MPV17 protein is a hydrophobic membrane protein of 176 amino acids and unknown function. Initially localised 
in murine peroxisomes, it was later reported to be a mitochondrial inner membrane protein in humans and in yeast. 
To resolve this contradiction we tested two new mouse monoclonal antibodies directed against the human MPV17 
protein in Western blots and immunohistochemistry on human U2OS cells. One of these monoclonal antibodies 
showed specific reactivity to a protein of 20 kD absent in MPV17 negative mouse cells. Immunofluorescence studies 
revealed colocalisation with peroxisomal, endosomal and lysosomal markers, but not with mitochondria. This data 
reveal a novel connection between a possible peroxisomal/endosomal/lysosomal function and mitochondrial DNA 
depletion.
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Findings
Background
Mutations in the human MPV17 gene have been firstly 
discovered to be causal for the lethal liver disease Mito-
chondrial DNA Depletion Syndrome (MDDS) by Spi-
nazzola et al. in 2006 [21]. Since then various additional 
mutations within this gene were described to cause the 
syndrome [5, 8, 23]. In contrast to other proteins of 
which gene mutations cause MDDS such as POLG, TK2, 
or DGOUK [4], this protein is not obviously involved in 
replication or in nucleic acid metabolism, but appears 
to be a membrane protein of unknown molecular func-
tion [21, 25, 26]. MPV17 gene knockout in mice has been 
described earlier as causal of glomerulosclerosis [2, 14, 
25] and inner ear disease [11], reminiscent of chemical 
damage by Adriamycin [15]. Although these mice also 
showed mitochondrial DNA depletion, they displayed no 
major liver phenotype [24]. A functional link between the 
PRKDC repair protein, the mouse kidney phenotype as 
well as the mitochondrial depletion phenotype has been 
established by Papeta et  al. [15]. Human MPV17 pro-
tein expression can rescue the phenotype in transgenic 
mice, negative for murine MPV17 [20]. A functional 
homolog of the MPV17 protein was identified in yeast 
(Sacharomyces cerevisiae) and the human gene can res-
cue the yeast phenotype in Sym1 negative yeast as well 
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[22]. In addition, a mutant in the zebra fish (Dario rerio) 
MPV17 homolog tra has been described [12]. The yeast 
and fish mutant phenotypes appear remarkably different 
from the mutant phenotypes in mammals: Sym 1 nega-
tive yeast fails to grow at elevated temperature in ethanol 
[22], while tra negative fish are viable but show a trans-
parent appearance [12]. Finally, MPV17 is a member of 
a protein family, including MPV17 like proteins [6, 19] 
and the peroxisomal membrane protein PXMP22 [7, 18]. 
The hypothesis that MPV17 protein might constitute a 
channel allowing—in vertebrates—nucleotides or—in 
yeast—metabolic intermediates to pass though internal 
membranes was recently reviewed [13].
The publication describing the causative role of MPV17 
mutations in the human liver disease MDDS included 
an analysis of the intracellular localisation of the MPV17 
protein in human cells based mainly on studies of trans-
fected cells over-expressing a c-terminally tagged recom-
binant protein, it was stated that this protein localised 
to the inner membrane of mitochondria [21]. Support-
ing this notion, it has been established that the yeast 
homolog of MPV17, SYM1, indeed localises to this cell 
compartment [17, 22]. An earlier study [26], however, 
had localised the MPV17 gene product to peroxisomes, 
again based on immunofluorescence data and supported 
by the similarity of the protein to the bona-fide peroxiso-
mal membrane protein PXMP22 [7].
To clarify this contradiction we here present co-locali-
sation studies using novel anti-human MPV17 monoclo-
nal mouse antibodies.
Methods
Cell lines and tissue culture
Human osteosarcoma cells (U2OS) cells were origi-
nally obtain from the American tissue culture collection 
(ATCC® HTB-96™), kept at the Heinrich Pette Insti-
tut for several years and used in [10]. Primary murine 
embryonic fibroblasts (MEF) were produced from day 
11 MPV17  +/+  and MPV17  −/−  embryos respectively 
according to Zwacka et  al. [26]. U2OS and mouse MEF 
cells were cultured under standard conditions. Stable 
transformants were selected using 1  mg/ml G418 (Life 
Technologies). Hybridomas were generated as described 
[26], and clones were grown in RMPI media including 
10–20 % FCS. The clones were monitored for IgG produc-
tion by immunoblotting using anti-IgG antibodies and the 
ECL System (Pierce) for detection. Antibodies were puri-
fied using a Protein G Sepharose column (Life Technolo-
gies) according to the manufacturer’s instructions.
Antibodies and organelle detection
Commercial primary antibodies against MPV17 were: 
mouse monoclonal anti-human MPV17 antibody 
(60103-1-Ig, Proteintech), rabbit anti-human MPV17 
polyclonal antibody (10310-1-AP, Proteintech); rab-
bit anti-human MPV17 polyclonal antibody (ab93374, 
Abcam); goat anti-human MPV17 polyclonal antibody 
(sc-109551, Santa Cruz), rabbit anti-MPV17 C-terminal 
region polyclonal antibody ARP73712-P050 Insight Bio-
technology), rabbit anti-MPV17 N-terminal region poly-
clonal antibody AP8749a-ev-AB, BioCat).
Further primary antibodies used were: mouse poly-
clonal anti-human catalase antibody (Abcam ab88650); 
mouse monoclonal anti-complex IV mitochondrial subu-
nit I (Invitrogen 459600); rabbit polyclonal anti-human 
PMP70 antibody (gift from Wilhelm Just, University of 
Heidelberg); rabbit anti-human Rab 7 antibody (Sigma 
R4779); goat anti- human cathepsin D antibody (Santa 
Cruz sc 6486); rabbit anti-human EEA1 antibody (Novus-
Biologicals, NB-300-502); goat anti-human LAMP1 anti-
body (Santa Cruz, sc 8098); mouse monoclonal anti-flag 
antibody (Sigma, M2, F3165), mouse monoclonal anti-
human beta-actin antibody (Sigma, AC74, A5316).
Primary monoclonal Antibodies 5D2 and 6F5 were 
isolated from mass cultures and purified over protein 
G Sepharose (Life Technologies). A Rabbit polyclonal 
anti-human PMP70 antibody was a gift from Wilhelm 
Just, University of Heidelberg. Further primary antibod-
ies used were: rabbit anti-human Rab 7 antibody (Sigma 
R4779); goat anti-human cathepsin D antibody (Santa 
Cruz sc 6486); rabbit anti-human EEA1 antibody (Novus-
Biologicals, NB-300-502); goat anti-human LAMP1 
antibody (Santa Cruz, sc 8098); mouse monoclonal anti-
human beta-actin antibody (Sigma, AC74, A5316).
Secondary antibodies: HRP labeled anti-mouse IgG 
antibody (Pierce); Alexa Fluor 555 and Alexa Fluor 488 
with appropriate anti-mouse, anti-rabbit, and anti-goat 
specificity were from Life Technologies. For mitochon-
drial staining, MitoTracker Red 7510 was employed 
according to the manufacturer’s instructions.
Cell extracts and immunoblotting
Cell extracts were prepared and the immunoblotting was 
performed as described by Kinkley et al. [10] and Pircher 
et al. [16].
Immunofluorescence analysis
Immunofluorescence analysis was performed essentially 
as described by Kinkley et  al. [10]. In brief, cells were 
grown on cover slips, fixed with 4  % paraformaldehyde 
in PBS (10  min at room temperature), washed twice 
with PBS, permeabilized with 0.5 % Triton X-100 in PBS 
(10 min at room temperature), washed three times in PBS 
and then blocked for 1 h (at room temperature) or over-
night (4 °C) with 3 % BSA in PBS. Cover slips were then 
incubated in 200 μl of primary antibodies, diluted 1/200 
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in PBS, for 1  h, washed three times with PBS and then 
incubated with the appropriate secondary antibodies for 
1 h. The cover slips were then washed three more times in 
PBS and mounted on slides using Mowiol (Calbiochem). 
The cells were analyzed by indirect immunofluorescence 
microscopy using a Zeiss LSM confocal microscope or 
a MicroRadiance confocal scanning system (Bio-Rad) in 
combination with a Zeiss Axiophot microscope (Fig. 1). 
Colocalisation analysis was performed with Fiji (Image J).
Plasmid constructs
An MPV17 expression construct (SC118652) was from 
origene. For details see: www.origene.com/cdna/.
Results
Commercially available anti-human MPV17 antibod-
ies from different sources (Abcam ab93374; Protein-
tech 10310-1-AP, 60310-1-Ig; Santa Cruz Biotechnology 
SC109551; Insight Biotechnology ARP73712-P050; Bio-
Cat AP8749a-ev-AB) were tested in western blot (Fig. 1) 
and immunofluorescence studies (Fig. 2) on human oste-
osarcoma cells (U2OS) transfected with a human-MPV17 
expression construct (Origene SC118652). The polyclonal 
antibody ab93374—as the only one yielding reproducible 
results-, revealed a band at the expected size of 20  kd 
in western blot (Fig.  1 left panel) and a punctuate pat-
tern in the immunofluorescence analyses (Fig. 2). When 
analysed for colocalisation with anti-complexIV mito-
chondrial subunit antibodies for mitochondrial and with 
anti-catalase antibodies for peroxisomal localisation, 
the Image J program revealed positive colocalisation for 
both. Remarkably, in both, western blot and immunoflu-
orescence analyses, ab93374 reactivity was only detected 
in MPV17 expression construct transfected cells (Fig.  1 
left panel, Fig. 2), while endogenous MPV17 protein was 
not traceable. Thus the ab93374 reaction was not very 
sensitive, because the endogenous MPV17 gene has been 
shown to be almost ubiquitously expressed at relatively 
high levels [25]. Furthermore, the apparent ambiguous 
localisation was unexpected, suggesting being poten-
tially caused by transfection and overexpression artifacts. 
Therefore, mouse monoclonal antibodies raised against 
a recombinant Glutathion-S-Transferase (GST)-human 
MPV17 fusion protein, in which GST was fused to the 
N-terminus of MPV17 [26], were studied. Two of them 
were reactive to the bacterially expressed fusion protein 
but not to GST alone [26].
These two, 6F5 and 5D2, were tested on Western blots 
of human U2OS cell extracts (Fig. 1, central panel). Both 
showed reactivity against a protein of the expected size 
Fig. 1 Western blot immunoreactivity of the polyclonal anti‑MPV17 antibody Ab 93374 (left) and the monoclonal anti‑ human MPV17 antibod‑
ies 6F5 and 5D2 on extracts of human and murine cells of different MPV17 genotypes. Left extracts from human U2OS cells, untransfected or 
transfected with the MPV17 expression clone SC118652 (origene), were probed with the antibody ab 93374 (abcam). Center untransfected U2OS 
cells with MPV17 +/+ endogenous genotype probed with the monoclonal antibodies 6F5 and 5D2. Right Murine embryo fibroblast (MEF) cells of 
MPV17 +/+ or MPV17‑/‑ genotype probed with the monoclonal antibodies 6F5 and 5D2. Indicated marker sizes were transferred from Ponceau 
stained marker bands run in parallel. Loading was controlled as indicated by reaction of the filters with an anti‑ß‑actin antibody. 10 μg of protein 
were separated on SDS gels and analysed by Western blot according to [16] (left panel), and Kinkley et al. [10] respectively
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of approximately 20 kD. 6F5, however, recognised a num-
ber of additional bands evidencing cross-reactivity with 
other proteins. 5D2, by contrast, only detected a sin-
gle band at 20  kD, the expected size. To investigate the 
specificity of these signals MPV17 negative cells were 
necessary. For lack of such human cells from MDDS 
patients we tested these antibodies on extracts of mouse 
embryo fibroblasts (MEF) derived from MPV17 +/+ and 
MPV17  −/−  cells from MPV17 knockout mice [26], 
respectively (Fig.  3, right panel). It revealed that the 
20 kD band recognised by 6F5 was indeed the only one 
missing in MPV17  −/−  cells, indicating that this band 
actually represented the MPV17 protein. 5D2, in con-
trast to the human cells, only showed a very weak sig-
nal on the mouse cells but this was again specific for the 
MPV17 positive genotype. Taken together, 6F5 recog-
nised an epitope on the MPV17 protein, which this pro-
tein shares with a number of other proteins. On the other 
hand, 5D2 apparently displays exclusive anti-MPV17 
reactivity, strong in human U2OS cells but very weak in 
murine cells MPV17 positive and absent in MPV17 nega-
tive cells. This may indicate, that 5D2 is specific for a 
human specific epitope on the MPV17 protein, which is 
92 % identical between mouse and man [9]. Because the 
anti-human antibody was raised in mice, there might be 
a preference for such epitopes in the immune response.
When tested in immunofluorescence studies on U2OS 
cells, 6F5 did not display specific reactivity (data not 
shown), while 5D2 generated a characteristic punctate 
pattern, which in the Image J analysis of confocal micro-
scopic pictures showed partial colocalisation with the 
peroxisomal marker PMP70 (polyclonal rabbit PMP70 
antibody, gift from W. Just, University of Heidelberg), 
(Fig. 3 top). However, the pattern did not coincide with 
mitochondrial staining as displayed by MitoTracker Red 
(MP07510, Invitrogen) (Fig. 3 bottom). Thus, the staining 
pattern was not exclusively peroxisomal and not mito-
chondrial, as had been reported for MPV17 localisation 
in earlier studies, respectively [21, 26].
In search of other co-localising structures, experi-
ments were performed with markers for other organels. 
As depicted in Fig.  4 we found partial colocalisation to 
a marker of the early endosomal compartment, EEA1 
(Fig. 4 top), while there was no apparent co-localisation 
Fig. 2 Ab93374 (Abcam) recognizes MPV17 specific structures in U2OS cells transiently transfected with an MPV17 expression construct in immu‑
nofluorescence analysis. Ab93374 signal (green) is largely missing in nontransfected cells. The immunoreactivity does colocalise with peroxisomal 
(anti‑catalase, mouse polyclonal, Abcam ab88650) and mitochondrial (anti‑complex IV mitochondrial subunit I, mouse monoclonal, Invitrogen 
459600) markers (red). Immunofluorescence (IF) method was according to Pircher et al. [16] using a MicroRadiance confocal scanning system (Bio‑
Rad) in combination with a Zeiss Axiophot microscope. Colocalisation analysis was performed using the Fiji software of Image J and is illustrated by 
white dots
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with RAB7, a marker of the late endosomal compart-
ment (data not shown). In addition, clear colocalision 
was detected with Cathepsin D (not shown) and LAMP 
1 (Fig. 4 bottom). Figure 5 shows a single cell analysis of 
LAMP1—5D2 costaining, in which in addition the opti-
cal overlay colocalisation was added to the mathematical 
colocalisation analysis by the Fiji software of the ImageJ 
program package. Thus, 5D2 recognizes a structure that 
is present in endosomes and lysosomes in addition to 
peroxisomes. This in marked contrast to earlier localisa-
tions of MPV17 with different antibodies.
Conclusions
In this work we have characterised two monoclonal anti-
bodies raised against a bacterially expressed N-terminal 
GST fused to the human MPV17 protein. These antibod-
ies, specific for the MPV17 part of the fusion protein rec-
ognise a band of the expected size in human U2OS cells. 
While 6F5 cross reacts with other proteins 5D2 appears 
to be monospecific. 5D2 creates a punctate pattern in 
immunofluorescence studies partially colocalising with 
peroxisomal, early endosomal, and lysosomal markers 
but not with mitochondria. 5D2 does bind only weakly 
but specifically to the murine MPV17 homolog (Fig.  1), 
suggesting that the mouse monoclonal might bind to 
an epitope where murine and human MPV17 diverge. 
This could be the c-terminus of the molecule, which is 
the region of strongest divergence. In line with this idea 
is the fact that the c-terminus of the MPV17 molecule 
was exposed in the bacterial n-terminal fusion to GST 
antigen used for immunisation. Moreover, MPV17 mol-
ecules fused at the c-terminus to other proteins cannot 
be detected by 5D2 (data not shown).
The commercial anti-human MPV17 antibody used 
in our first approach was a polyclonal rabbit antibody 
raised against GST-MPV17 fusion protein (abcam ab 
93374) and has produced erroneous or ambiguous results 
(Fig.  2). The rabbit polyclonal antibody from Protein-
tech used by [21] leading to mitochondrial localisation 
was raised against the identical GST-MPV17 fusion and 
might have been error—prone as well. Furthermore, in 
addition to possible transfection artifacts, MPV17 and 
Fig. 3 In U2OS cells, 5D2 antibody detects a punctate pattern colocalising with a peroxisomal (PMP70) but not with a mitochondrial (MitoTracker) 
marker. Top Rabbit anti PMP70 antibody (decorated green) was a gift from W. Just, Heidelberg. Secondary antibodies: Alexa Fluor 555 anti‑mouse and 
Alexa Fluor 488 anti‑rabbit. Bottom Mitotracker 7510 (Invitrogen) was used as recommended by the supplier. Secondary antibody: Alexa 488 anti‑
mouse. IF method and microscopy according to Kinkley et al. [10] using a Zeiss LSM confocal microscope. Mathematical colocalisation analysis was 
performed using the Fiji software of Image J and is illustrated by white dots
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Fig. 4 5D2 colocalisation with a marker of early endosomes (EEA1) and lysosomes (LAMP1) in U2OS cells. Top Partial colocalisation of 5D2 with 
EEA1 (rabbit anti‑human). Bottom colocalisation of 5D2 with LAMP1 in U2OS cells. The IF method, secondary antibodies, and Image J analysis were 
used as described in the legend of Fig. 3
Fig. 5 Colocalisation of 5D2 and LAMP1 mediated immunofluorescence in a U2OS single cell. IF and analysis of 5D2 and Colocalisation of 5D2 with 
LAMP1 in U2OS cells. The IF method, secondary antibodies, and Image J analysis were used as described in the legend of Fig. 3. In addition a merge 
of the two immunofluorescence pictures is depicted
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related proteins such as PXMP22 may localise errone-
ously, when they are fused to detection tags (unpublished 
and [3].
MPV17 deficiencies in humans can cause fatal liver 
disease mediated by mitochondrial DNA depletion in 
liver cells [21]. However, primary human liver cells were 
not available for our studies. We therefore had to per-
form this study on unrelated human tumour cells, and 
it is possible, that the MPV17 protein might localise dif-
ferently in different cell types. Yet, preliminary studies 
on human primary skin fibroblasts show MPV17 colo-
calisation with LAMP1 as well (unpublished results) 
and thus corroborate the data on U2OS cells presented 
above. Thus, our data raise the question of how the 
mitochondrial MDDS phenotype is generated if the 
MPV17 gene product is found mainly in other orga-
nelles. It has been shown that MPV17 protein forms 
a membrane channel with a diameter allowing low 
molecular weight molecules to pass [1] but the role of 
the channel is still elusive, particularly considering the 
different phenotypes that mutations of it can cause in 
different species [13]. We look forward to provide the 
antibodies described here to approach these open 
questions.
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